NeuPath Health Inc (NPTH) — Capital Reinvestment Ratio
NeuPath Health Inc (NPTH) has a Capital Reinvestment Ratio of 0.37x as of December 2025, meaning it reinvests 0% of its operating cash flow (CA$662.00K) in capital expenditures (CA$245.00K). See NeuPath Health Inc (NPTH) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NeuPath Health Inc Capital Reinvestment Ratio (2021–2025)
This chart tracks NeuPath Health Inc's Capital Reinvestment Ratio across 5 annual periods. Check NeuPath Health Inc (NPTH) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for NeuPath Health Inc (2021–2025)
Year-by-year Capital Reinvestment Ratio for NeuPath Health Inc from 2021 to 2025. For live market cap and broader valuation context, see NeuPath Health Inc (NPTH) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CA$4.00 Million | CA$863.00K | ▼ -40.7% |
| 2024 | 0.36x | CA$2.61 Million | CA$948.00K | ▲ +212.1% |
| 2023 | 0.12x | CA$3.03 Million | CA$353.00K | ▼ -93.0% |
| 2022 | 1.67x | CA$738.00K | CA$1.23 Million | ▲ +679.4% |
| 2021 | 0.21x | CA$1.92 Million | CA$411.00K | — |